Ads
related to: hepatitis c- Dosage & Administration
Get Dosage & Administration Info
For A Pangenotypic Treatment Option
- Clinical Study Results
Read About Study Results For A
Pangenotypic Hep C Treatment Option
- Patient Site
Considering Treatment? Visit The
Official Patient Site To Learn More
- Clinical Study Designs
Learn More About The Study Designs
For A Pangenotypic Treatment Option
- Safety Information
Find Out More About Safety Info
For A Pangenotypic Treatment Option
- Access & Resources
Help Your Patients Access A
Pangenotypic Hep C Treatment Option
- Dosage & Administration
Search results
Results From The WOW.Com Content Network
290,000 (2019) [4] Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; [2] it is a type of viral hepatitis. [6] During the initial infection period, people often have mild or no symptoms. [1] Early symptoms can include fever, dark urine, abdominal pain, and yellow tinged skin. [1]
The hepatitis C virus (HCV) [3] is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated HCC) and lymphomas in humans. [4][5]
“Hepatitis C is a blood-borne virus,” says Dr. Dieterich. “It is transmitted through the blood, so IV drug use is a major driver of the virus, especially now due to the heroin epidemic.
A hepatitis C vaccine, a vaccine capable of protecting against the hepatitis C virus (HCV), is not yet available. Although vaccines exist for hepatitis A and hepatitis B, development of an HCV vaccine has presented challenges. [1] No vaccine is currently available, but several vaccines are currently under development. [2][3]
Mar. 14—Hepatitis C is a liver infection caused by the hepatitis C virus. It is becoming a big public health concern in many counties, including Lawrence County, encouraging us to review some ...
Hepatitis C is a viral infection impacting millions of people in the world. Nearly 58 million people worldwide have hepatitis C, with an estimated 2.4 to 3 million people living with it in the ...
Ads
related to: hepatitis c